About Vitrolife A/S

Vitrolife A/S is a global medical technology company dedicated to reproductive health, primarily supporting IVF (in vitro fertilization) clinics and their patients. The company develops, manufactures, and markets a comprehensive portfolio of medical devices, genetic testing services, and advanced software solutions. Their offerings include culture media, time-lapse incubators (such as EmbryoScope), and embryo evaluation systems, all designed to optimize IVF procedures and improve treatment outcomes.

Vitrolife emphasizes innovation in embryo culture, selection, and genetic analysis, leveraging both hardware and AI-driven digital health tools. The company’s mission is to enable people to fulfill the dream of having a healthy baby by providing high-quality brands, outstanding service and support, and a focus on continuous research and development. They also offer pioneering genetic tests through their Igenomix portfolio, which assists reproductive health professionals in diagnosing and treating patients across preconception, pre-implantation, and prenatal phases.

Focus Areas

Reproductive health Assisted Reproductive Technology (ART) In Vitro Fertilization (IVF) genetic testing embryo assessment time-lapse technology AI technology automation digitalization medical devices culture media cryopreservation solutions instruments

Business Intelligence

TechnologyEnd-to-end platform for IVF workflow automation, standardization, and digitalization; utilizes deep learning and neural networks for AI-based imaging analysis tools with time-lapse incubators (e.g., EmbryoScope)

What Physicians Need to Know

Reproductive Health & IVF Solutions
Vitrolife Group is a global leader in reproductive health, specializing in In Vitro Fertilization (IVF) and offering a comprehensive portfolio of products and services that cover the entire reproductive-health journey.
Genetic Testing
Through its Igenomix portfolio, Vitrolife provides pioneering genetic tests to assist reproductive health professionals in analyzing and treating patients before, during, and after their reproductive journey, with the aim of a healthy baby.
Embryo Assessment & Time-Lapse Technology
Vitrolife pioneers time-lapse technology with its EmbryoScope+ systems, enabling continuous, undisturbed monitoring of embryo development, optimizing selection, and streamlining workflows.
AI Technology & Automation
Vitrolife leverages AI and advanced software solutions for embryo evaluation, helping to rank viable embryos for selection and transfer, and supporting elective single embryo transfer. They are also advancing automation to handle repetitive tasks, improve consistency, and enhance efficiency in IVF labs.
Medical Devices & Consumables
The company develops, manufactures, and markets a wide range of medical devices and consumables for IVF, including oocyte retrieval needles, culture media, cryopreservation solutions, pipettes, labware, and micro-laser platforms.
Digitalization & Workflow Efficiency
Vitrolife's technologies, including time-lapse systems and witnessing systems like eWitness, are designed to improve workflow efficiency, enable flexible scheduling, and ensure secure, error-free processes in IVF clinics.
Research & Development
With a 30-year track record of innovation, Vitrolife collaborates with universities and clinics globally, focusing on groundbreaking research and continuous product development grounded in science and advanced research capabilities.
Physician Tip

Vitrolife's integrated approach, combining high-quality medical devices, advanced genetic testing (Igenomix), and cutting-edge technologies like time-lapse incubators with AI-driven embryo assessment, offers physicians a comprehensive solution for improving IVF success rates. Their focus on undisturbed embryo culture, precise evaluation tools, and workflow optimization can lead to more efficient lab operations and better patient outcomes. The extensive clinical and scientific support, along with educational resources through Vitrolife Academy, provides valuable assistance for optimizing IVF procedures and staying updated on the latest advancements. The ability to track embryo development continuously and utilize AI for ranking embryos can enhance decision-making for embryo transfer and genetic testing.

Vitrolife's offerings are designed to integrate seamlessly across the entire IVF journey, from oocyte retrieval to cryopreservation. Their time-lapse systems and AI tools can be integrated with existing lab workflows to enhance embryo selection and management. The company has also engaged in partnerships, such as with GE Healthcare, to improve ART offerings and connect the patient journey in and out of the IVF clinic. Their digital product owner roles suggest ongoing development in EMR and API integration.

Products by Vitrolife A/S

No products listed for this company yet. Know of one? Suggest it →

Videos

News, demos, and interviews about Vitrolife A/S.

Loading videos...

Videos load interactively. If none appear, search YouTube for Vitrolife A/S →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Vitrolife A/S provides a comprehensive portfolio of medical devices and genetic testing services that cover the entire reproductive health journey. Their offerings span the IVF workflow, including oocyte retrieval needles, sperm preparation media, embryo culture media (like G-TL), embryo transfer media (such as EmbryoGlue), and cryopreservation solutions and devices.
Vitrolife A/S integrates time-lapse technology, such as the EmbryoScope+ system, for continuous and undisturbed embryo monitoring. They utilize AI-based tools like iDAScore and Guided Annotation to provide objective embryo ranking based on implantation likelihood, which streamlines evaluation and enhances embryo selection for improved IVF outcomes.
Through the acquisition of Igenomix, Vitrolife Group offers a complete genetic testing portfolio for reproductive health professionals, including pioneering tests for various stages of the reproductive journey. They ensure compliance by classifying products as medical devices, adhering to international regulatory standards like CE mark, FDA-clearance, and TGA-approval, and maintaining quality accreditations for genetic laboratories such as CLIA.
Vitrolife A/S supports automation and digitalization with solutions like eWitness and EmbryoScope integration, which automate patient registration and synchronize data to create streamlined, error-free, and audit-ready lab workflows. They offer extensive clinical and scientific support globally through a network of embryologists and genetic counselors, providing education and training via platforms like Vitrolife Academy to optimize IVF processes.
Vitrolife Group is a world-leading global provider of medical devices and genetic testing services in reproductive health, with over three decades of innovation and a strong presence in more than 125 markets. They actively collaborate with universities and clinics for research and development, positioning themselves as a trusted partner for healthcare providers seeking to improve patient outcomes through quality and innovation.
While specific pricing details are not publicly available, Vitrolife's solutions are designed to enhance workflow efficiency, reduce manual workload through automation, and improve embryo selection with advanced time-lapse and AI technologies. These efficiencies contribute to cost-effectiveness for high-volume IVF centers by aiming for better patient outcomes and potentially reducing overall treatment costs per successful pregnancy.
Vitrolife A/S offers various medical devices and instruments for IVF, including oocyte retrieval needles (e.g., Sense), embryo transfer catheters, micro-laser platforms for techniques like assisted hatching, and time-lapse incubators such as EmbryoScope+. They ensure quality and reliability through a comprehensive quality control program, extensive testing that exceeds regulatory demands, and adherence to medical device directives (e.g., CE mark, FDA-clearance), guaranteeing safe, non-toxic, and consistently high-quality products.
Vitrolife A/S's R&D priorities include continuous improvement of existing products and the development of new offerings in their state-of-the-art laboratories, often in collaboration with external universities and clinics. Future innovations focus on advancing AI, automation, genetic screening, and data analytics to enable more personalized, efficient, and accessible IVF treatments, with a strategic vision to create a connected platform across the entire IVF workflow.

Related Companies

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

RTW.ai provides scaled CPA services, offering productized accounting, tax preparation, and quarterly insights specifically for owner-led businesses in healthcare, professional services, and the trades. The company aims to eliminate the common frustrations associated with traditional accounting services, such as slow response times and lack of proactive tax planning. They commit to closing books by the […]

Infinitus is a healthcare AI company that develops voice AI agents and copilots to automate administrative workflows for physicians and healthcare providers. The company aims to reduce the complexity and cost of healthcare by handling time-consuming and repetitive phone-based tasks, such as benefit verifications, prior authorizations, patient outreach, and member engagement. By automating these processes, […]

Trainio is an AI roleplay training platform specifically designed for healthcare teams. It allows medical staff, including front desk personnel, call center agents, caregivers, nurses, and pharmacists, to practice challenging patient and family conversations with realistic AI avatars. These scenarios cover a wide range of situations, such as de-escalation of angry patients, communication with individuals […]

Confido Health is an AI-powered healthcare operations platform designed to alleviate administrative burdens for physicians and healthcare providers. The company develops AI agents that automate routine tasks and workflows across various aspects of healthcare operations, including front, mid, and back office functions. This allows medical staff to dedicate more time to direct patient care, improving […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.